Home » Topics » BioWorld Science

BioWorld Science
RSS

Prodrug form target of JBP-485 and vitamin E developed to treat NASH

Jan. 3, 2022

New DNA intercalator/topo II inhibitor shows improved anticancer activity over doxorubicin

Jan. 3, 2022

Preprints age well, manuscript preprint shows

Jan. 3, 2022

Nephrology

Jan. 1, 2022

Hematologic

Jan. 1, 2022

Cardiovascular

Jan. 1, 2022

Dermatologic

Jan. 1, 2022

Respiratory

Jan. 1, 2022

Shark variable new antigen receptors identified which neutralize SARS-CoV-2 virus

Dec. 31, 2021

ERRalpha inverse agonist shows significant in vivo activity against breast cancer

Dec. 31, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...